Navigation Links
An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes

ate (ISR) and the characterization of the ISR into static (beta cell responsiveness to above-basal glucose following a meal) and dynamic (beta cell responsiveness to the rate of increase in above-basal glucose following a meal) components.

After 24 weeks, the changes in static and dynamic beta cell responsiveness were increased across all active treatments relative to placebo, and appeared to be increased in an approximately additive fashion with co-administration with JANUVIA and high dose metformin compared to each as monotherapy. The results of the beta cell modeling analysis showed that the addition of JANUVIA to metformin resulted in a 49 percent increase in measured change in static beta cell responsiveness compared with metformin alone (20.1, JANUVIA 50 mg/metformin 1000 mg twice daily vs. 13.5, metformin 1000 mg twice daily). Further, the addition of JANUVIA to metformin resulted in a 114 percent increase in measured change in dynamic beta cell responsiveness compared with metformin alone (151.0, JANUVIA 50 mg/metformin 1000 mg twice daily vs. 70.7, metformin 1000 mg twice daily).

"These data further characterize the effects of DPP-4 inhibition and its role in combination with metformin, the most commonly prescribed drug for type 2 diabetes," said Luciano Rossetti, senior vice president and MRL head, Diabetes & Obesity and Cardiovascular Franchises, Merck & Co., Inc.

JANUVIA and metformin had a complementary effect to increase active GLP-1 concentrations in healthy adults (0286-OR; Study #050)

A randomized, placebo-controlled, double-blind, clinical pharmacology study was conducted in 16 healthy adults to assess the potential complementary effects of JANUVIA and metformin on GLP-1, an important incretin hormone. In each 2-day treatment period, subjects received one of four treatments: JANUVIA, metformin, the co-administration of JANUVIA and metformin, or placebo.

In this study, JANUVIA and metformin, when taken sepa
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
3. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
4. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
5. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
6. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
7. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
10. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
11. Investigational Study Evaluates the Effectiveness of Aripiprazole in Adolescents With Schizophrenia
Post Your Comments:
(Date:5/16/2013)... MECHELEN, Belgium , May 17, 2013 /PRNewswire/ ... ABBV ) announced today an extension of their ... will fund and complete a Phase 2 program in ... into Phase 3.  Upon successful completion of the study, ... million.  The terms of the collaboration extension are in ...
(Date:5/16/2013)... May 16, 2013  Today, the National Patient Advocate ... House of Representatives recently approved a bill that ... charging patients higher out-of-pocket fees for newer, more expensive ... which have more severe side-effects. However, the bill was ... which will continue to be a barrier to patients ...
(Date:5/16/2013)...  Amgen (NASDAQ: AMGN ) will participate in ... 2013, at the Sheraton New York Times Square in ... Eastern Daylight Time. Joseph P. Miletich , ... Amgen, will present at the conference. Live audio of the ... website, www.amgen.com , under Investors. A replay of the ...
Breaking Medicine Technology:AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3
... June 17 Neurocrine Biosciences, Inc. (Nasdaq: ... worldwide collaboration with Boehringer Ingelheim to research and develop ... II diabetes and other indications.  The companies will work ...  Boehringer Ingelheim is responsible for the global development and ...
... June 17, 2010 The Medical Device practice at,MarketsandMarkets is pleased to ... , India , China (BRIC) 2010 - 2015. , ... Browse in-depth TOC on ... China (BRIC) 2010 - 2015 Market Report. Early buyers will receive 10%,customization ...
Cached Medicine Technology:-- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes 2-- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes 3Diagnostic Imaging Markets in Brazil, Russia, India, China (BRIC) 2010 - 2015: MarketsandMarkets 2Diagnostic Imaging Markets in Brazil, Russia, India, China (BRIC) 2010 - 2015: MarketsandMarkets 3Diagnostic Imaging Markets in Brazil, Russia, India, China (BRIC) 2010 - 2015: MarketsandMarkets 4
(Date:5/18/2013)... Hayden, ID (PRWEB) May 18, 2013 ... needs when it comes to safety and comfort ... these requirements and provides clients with an effective ... System®. This is an integrated, turnkey communications ... of care, while allowing residents independence and privacy. ...
(Date:5/18/2013)... May 17 (HealthDay News) -- It comes as little surprise ... that college women are more likely to drink unhealthy amounts ... Much of this difference is probably because the ... is much lower for women than it is for men: ... good reason for that difference. Women don,t metabolize alcohol in ...
(Date:5/18/2013)... York (PRWEB) May 18, 2013 As ... in courts throughout the country, Bernstein Liebhard LLP notes ... replacement patients often suffer tissue damage before they experience ... which according to Science Daily will appear in the ... replacement recipients underwent MRI screens of their hips. ...
(Date:5/18/2013)... May 18, 2013 6Webs.com is the ... to read reviews and comprehensive comparisons make 6Webs.com the ... security reviews. 6Webs.com just recently finished conducting their assessments ... , Tim Smythe from 6Webs.com reports, "There has been ... to their ease of use, expandability and mobility. Combine ...
(Date:5/18/2013)... Bay, CA (PRWEB) May 18, 2013 ... , has recently completed a stylish renovation that features ... advanced specialties. , From the ground up, this ... improved with fresh flooring, soothing colors and comfortable spa ... been installed, including an Apilus epilator machine. The ...
Breaking Medicine News(10 mins):Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 3Health News:College Women More Prone to Problem Drinking Than Men: Study 2Health News:College Women More Prone to Problem Drinking Than Men: Study 3Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 2Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 3Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 4Health News:Best Wireless Home Security System Companies Released by 6Webs.com 2Health News:Rio Salon and Spa, a Beauty Salon in Morro Bay, Undergoes Makeover 2
... -- Seniors in long-term care facilities have a roughly ... they visit a hospital emergency department in the fall, ... Canadian researchers looked at 1,269 elderly residents of 22 ... Riviere-du-Loup, Quebec between September 2006 and May 2008. ...
... as simple as developing a taste for yerba mate tea? ... human colon cancer cells die when they are exposed to ... of this brew, which has long been consumed in South ... mate tea not only induced death in human colon cancer ...
... OAK BROOK, Ill. January 23, 2012 ... colonoscopy reporting in daily clinical practice and evaluated ... colonoscopy reporting varied significantly in clinical practice. Colonoscopy ... between endoscopy departments was found. Researchers concluded that ...
... forward. A trip to the Emergency Department (ED) is every ... a result of your child,s visit could help a child ... and his research team of leading pediatric emergency physicians at ... and the impact of their research is today recognized as ...
... -- A Kansas State University professor is turning to nutrition ... human nutrition, is helping men make more informed diet decisions ... risk of prostate cancer. Prostate cancer is one of the ... States. "I,m interested in researching ways to prevent prostate ...
... in the blood may signal a risk two times higher ... to medical researchers. "Past studies (in cadavers) have ... from individuals with cancer have higher lead levels," said Emily ... "But prior to this study, the identification of higher lead ...
Cached Medicine News:Health News:Certain Seniors at Risk for Infection After ER Visit: Study 2Health News:Compounds in mate tea induce death in colon cancer cells 2Health News:Study examines quality of colonoscopy reporting and performance 2Health News:Study examines quality of colonoscopy reporting and performance 3Health News:Study examines quality of colonoscopy reporting and performance 4Health News:Pediatric emergency research team hit the mark 2Health News:Eating smart: Researcher studies foods, dietary supplements that may reduce risk of prostate cancer 2Health News:Lead blood levels may increase smokers' risk for kidney cancer 2Health News:Lead blood levels may increase smokers' risk for kidney cancer 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: